Ensign Peak Advisors’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$42K Hold
2022
Q1
$56K Hold
2021
Q4
$101K Buy
2021
Q2
Sell
2021
Q1
$758K Buy